There is no experimental evidence of embryonic or teratogenic effects attributable to cefuroxime axetil but, as with all drugs, it should be administered with caution during the early months of pregnancy. Cefuroxime is excreted in human milk, and consequently caution should be exercised when cefuroxime axetil is administered to a nursing mother.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
